Valganciclovir is not associated with decreased EBV infection rate in pediatric kidney transplantation

INTRODUCTION: Primary infection or reactivation of Epstein-Barr Virus (EBV) is a significant cause of morbidity and mortality in pediatric kidney transplantation. Valganciclovir (VGC) treatment is recommended for prophylaxis of cytomegalovirus infection, but its role for the prevention of EBV infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheyssac, Elodie, Savadogo, Hamidou, Lagoutte, Nathan, Baudouin, Véronique, Charbit, Marina, Novo, Robert, Sellier-Leclerc, Anne-Laure, Fila, Marc, Decramer, Stéphane, Merieau, Elodie, Zaloszyc, Ariane, Harambat, Jérôme, Roussey, Gwenaelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871758/
https://www.ncbi.nlm.nih.gov/pubmed/36704127
http://dx.doi.org/10.3389/fped.2022.1085101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871758/
https://www.ncbi.nlm.nih.gov/pubmed/36704127
http://dx.doi.org/10.3389/fped.2022.1085101

Ejemplares similares